ArticleBMC nephrology2025
Time course profiling of the kynurenine pathway activity in a pig model of crescentic glomerulonephritis.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
OBJECTIVE AND
designThe kynurenine (KYN) pathway is activated in acute kidney disease, including crescentic glomerulonephritis (CGN), an immune-mediated life-threatening syndrome characterized by rapid loss of renal function. The non-invasive measurement of KP metabolites may have clinical diagnostic or prognostic value, but has never been systematically studied using sensitive analytical tools.
methodsWe have recently developed and validated a sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to measure a comprehensive panel of tryptophan (TRP) catabolic intermediates in blood and urine. We used a novel model of CGN to approximate human biochemical and physiological parameters.
resultsWe show that for a period of 28 days after the onset of the disease, monitoring plasma KP is not informative as it is likely to reflect an accumulation of uremic retention solutes and does not allow to follow the activity of the disease over time. In contrast, the urinary metabolic profile is noteworthy, with an early and significant yet transient increase in urinary KYN/TRP ratio levels. Urinary KYN/TRP ratio is independent of proteinuria.
conclusionThese findings suggest that increased urinary KYN/TRP ratio levels by LC/MSMS in patients with CGN reflect early disease activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.